Therefore, co-players of up- and down-regulation of p53, such as 5′-Nucleotidase Domain-Containing Protein 2 (NT5DC2) may be targetable and are thus needed for biological and prognostic understanding of NSCLC. Here, NT5DC2 is linked to non-small cell lung carcinoma.